ANI Pharmaceuticals Inc (ANIP) Insider Trading
- $2,005,711.60
- $105,407,027.21
- March 13, 2025
- Muthusamy Shanmugam
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 14, 2018 | Director | 27,964 | $62.24 | Sell | $1,740,479.36 | |
| March 14, 2018 | Insider | 40,000 | $61.83 | Sell | $2,473,200.00 | |
| March 12, 2018 | Director | 64,221 | $63.03 | Sell | $4,047,849.63 | |
| March 8, 2018 | Director | 15,391 | $63.08 | Sell | $970,864.28 | |
| March 5, 2018 | SVP | 4,177 | $61.92 | Sell | $258,639.84 | |
| March 1, 2018 | SVP | 28,652 | $61.66 | Sell | $1,766,682.32 | |
| Aug. 22, 2016 | Insider | 37,455 | $66.97 | Sell | $2,508,361.35 | |
| Aug. 8, 2016 | VP | 12,500 | $67.06 | Sell | $838,250.00 | |
| Dec. 18, 2015 | VP | 3,500 | $43.26 | Sell | $151,410.00 | |
| Nov. 12, 2015 | CEO | 2,500 | $40.95 | Buy | $102,375.00 | |
| March 19, 2015 | VP | 15,000 | $66.50 | Sell | $997,500.00 | |
| Sept. 15, 2014 | Director | 3,000 | $27.49 | Buy | $82,470.00 | |
| Sept. 9, 2014 | CEO | 1,000 | $26.50 | Buy | $26,500.00 | |
| June 18, 2014 | VP | 5,000 | $34.28 | Sell | $171,400.00 | |
| May 8, 2014 | Director | 1,381 | $30.02 | Sell | $41,457.62 | |
| May 7, 2014 | Director | 2,000 | $30.38 | Buy | $60,760.00 | |
| March 21, 2014 | Director | 21,767 | $31.42 | Sell | $683,919.14 | |
| March 20, 2014 | major shareholder | 20,922 | $32.12 | Sell | $672,014.64 | |
| March 19, 2014 | Director | 25,358 | $33.68 | Sell | $854,057.44 | |
| March 18, 2014 | major shareholder | 60,540 | $34.07 | Sell | $2,062,597.80 | |
| March 13, 2014 | major shareholder | 87,723 | $32.48 | Sell | $2,849,243.04 | |
| Nov. 7, 2013 | Director | 9,000 | $11.27 | Buy | $101,430.00 | |
| Aug. 20, 2013 | Director | 10,000 | $7.47 | Buy | $74,700.00 |
Insiders are both buying and selling ANI Pharmaceuticals Inc stock.
The insider traders at ANI Pharmaceuticals Inc are: Muthusamy Shanmugam, Meredith Cook, Chad Gassert, Tracy Marshbanks, James G Marken, Meridian Venture Partners Ii L, Arthur Przybyl, Nikhil Lalwani, Robert W Schrepfer, Krista Davis, Patrick D Walsh, Thomas Haughey, Ross J Mangano, Stephen P Carey, Daniel Raynor, Ori Gutwerg, Jeanne Thoma, Christopher Mutz, David Nash, Antonio R Pera, Ross Mangano, and Renee P Tannenbaum
The most active insider trader at ANI Pharmaceuticals Inc is Muthusamy Shanmugam with 32 trades.
Meridian Venture Partners Ii L has sold the most ANI Pharmaceuticals Inc stock with a total value of $35,990,656.25.
Patrick D Walsh has bought the most ANI Pharmaceuticals Inc stock with a total value of $846,760.00.
The most recent insider trade for ANI Pharmaceuticals Inc was on March 13, 2025.
The single biggest insider buy for ANI Pharmaceuticals Inc was from Patrick D Walsh with a total value of $307,800.00 on Aug. 10, 2020.
The single biggest insider sell for ANI Pharmaceuticals Inc was from Meridian Venture Partners Ii L with a total value of $11,700,000.00 on Aug. 16, 2023.